Pediatrix Medical (MD) Non Operating Interest Expenses (2009 - 2026)

On a trailing twelve-month basis, Pediatrix Medical's Non Operating Interest Expenses was $33.3 million through Sep 30, 2026, down 9.8% year-over-year; for FY2025, it was $35.97 million, down 11.7% from FY2024.

• Non Operating Interest Expenses shows a five-year compound annual growth rate of -20.1% (FY2020 to FY2025).
• In earlier years, Non Operating Interest Expenses was $40.74 million in FY2024 (-3.2%), $42.08 million in FY2023 (+6.0%), $39.7 million in FY2022 (-42.2%) and $68.72 million in FY2021 (-37.8%).
• The Q3 2026 figure marks the lowest quarterly Non Operating Interest Expenses since Q3 2015.
• Compared with a year earlier, Non Operating Interest Expenses has declined for ten straight quarters, with an average decline of 10.0% over the last eight quarters.
• The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2023 (growth of 33.5%); the worst was Q2 2022 (a decline of 50.2%).
• Per Business Quant data, MD's Non Operating Interest Expenses in the three quarters before Q3 2026 was $8.17 million (Q2 2026), $8.27 million (Q1 2026) and $8.74 million (Q4 2025).